Occurred Cherkasy Oblast, Ukraine, July 2025. ''A huge frightening but beautiful cloud is approaching from afar and bringing ...

Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

Arcus Hunting, LLC, USA, the maker of Tink’s and Dead Down Wind hunting scents, announced a new licensing partnership to ...

As rain fell on Fermanagh, its people stood still for Victor Outram who was laid to rest on Sunday, July 12. Former principal ...

The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

Simon Arcus has resigned as the chief executive of the Wellington Chamber of Commerce and parent organisation Business ...

As rain fell on Fermanagh, its people stood still for Victor Outram who was laid to rest on Sunday, July 12.  Former principal of Enniskillen ...

Half the senior leadership team at the Wellington Chamber of Commerce and Business Central left the organisation in the six ...

Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...